Alzheimer’s disease
@article{Burns2009AlzheimersD, title={Alzheimer’s disease}, author={Alistair Burns and Steve Iliffe}, journal={BMJ : British Medical Journal}, year={2009}, volume={338} }
In this, the second of two review articles about dementia, we focus on Alzheimer’s disease, which is the most common cause of dementia. Dementia is a clinical syndrome characterised by a cluster of symptoms and signs manifested by difficulties in memory, disturbances in language, psychological and psychiatric changes, and impairments in activities of daily living. Alzheimer’s disease is a specific disease that affects about 6% of the population aged over 65 and increases in incidence with age…
421 Citations
Alzheimer’s Dementia: An Overview
- PsychologyJournal of the Indian Institute of Science
- 2017
Targeting these lifestyle-related factors in young adulthood and middle age may be protective against AD, as high educational achievement in early life, involvement in cognitively stimulating activity, physical activity and social engagement have been associated with reduced risk of late-life dementia and AD.
The Systemic Effects of Exercise on the Systemic Effects of Alzheimer’s Disease
- BiologyAntioxidants
- 2022
The systemic effects of both regular exercise and AD are summarized and it is pointed out how common exercise-induced adaptation via peripheral organs can decrease the incidence of AD or attenuate the progress of AD.
Alzheimer’s Disease and Herbal Combination Therapy: A Comprehensive Review
- Psychology, BiologyJournal of Alzheimer's disease reports
- 2020
The priority in AD research has remained to develop disease-modifying and development-reducing drugs for treatment regimens followed during the early and later stages, respectively.
Towards a Consensus on Alzheimer’s Disease Comorbidity?
- Medicine, BiologyJournal of clinical medicine
- 2021
Interestingly, the comorbid diseases are often degenerative diseases exacerbated by reactive oxygen species, thus underlining the potential role of antioxidants in the treatment of AD and comor bid diseases.
Amyloid beta hypothesis in Alzheimer's disease: Major culprits and recent therapeutic strategies.
- BiologyCurrent drug targets
- 2019
Some of the state of the art knowledge on the functional aspects of the key players involved in the amyloid hypothesis are presented and anti-amyloid agents present in the Phase III clinical trials are discussed.
Biomarkers in Mild Stages of Alzheimer’s disease: Utility in clinical practice and their relation with nutritional and lifestyle factors
- Medicine, Biology
- 2016
The utility of biomarkers in AD and nutritional and lifestyle factors used as treatment in mild stages are described and their utility in clinical practice relating this with nutritional andifestyle factors as possible treatment is defined.
Prevalence of Frailty in Mild to Moderate Alzheimer's Disease: A Systematic Review and Meta-analysis.
- Medicine, PsychologyCurrent Alzheimer research
- 2017
It was showed that frailty is highly prevalent in older patients with Alzheimer's disease in the community with the pooled prevalence of 31.9% and the true prevalence may be much higher given that end-stage patients may not be included.
Drug development for Alzheimer’s disease: review
- BiologyJournal of drug targeting
- 2018
The recent advance in AD drug development was reviewed and drug discovery programs under clinical trials targeting cholinergic system, α7 nicotinic acetylcholine receptors, N-methyl-d-aspartate receptor, β-secretase, γ- secretase modulators, tau, inflammatory mediators and glucagon-like peptide-1 (GLP-1) were discussed.
[Truth telling of Alzheimer's disease diagnosis].
- MedicineRevista medica de Chile
- 2012
The current state of literature on diagnostic truth telling in dementia is reported, the ethical principles involved are reviewed, and a strategy to address the issue is given.
References
SHOWING 1-10 OF 28 REFERENCES
The staging and assessment of moderate to severe Alzheimer disease
- PsychologyNeurology
- 2005
This review addresses the symptoms and staging of AD and emphasizes the key management issues, including gait and movement disorders, nutritional problems, and incontinence.
Psychiatric Phenomena in Alzheimer's Disease. III: Disorders of Mood
- Psychology, MedicineBritish Journal of Psychiatry
- 1990
Subjects with depressive symptoms had less cognitive impairment and less ventricular enlargement on CT compared with those without symptoms, and Widening of the interhemispheric fissure was associated with symptoms of mania but was inversely related to presence of depressive symptoms.
Advances in the early detection of Alzheimer's disease
- PsychologyNature Reviews Neuroscience
- 2004
Recent progress in the understanding of the evolution of early AD is reviewed with particular reference to the symptomatic pre-dementia stage designated 'mild cognitive impairment', emphasizing work on the early cognitive profile and associated neuroimaging studies.
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria
- BiologyThe Lancet Neurology
- 2007
Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers
- Medicine, PsychologyNeurology
- 1992
Criteria for the diagnosis of ischemic vascular dementia (IVD) broaden the conceptualization of vascular dementia, include the results of neuroimaging studies, emphasize the importance of neuropathologic confirmation, refine nosology, and identify areas that require further research.
Diagnosis and management of dementia with Lewy bodies
- Medicine, PsychologyNeurology
- 2005
The authors propose a new scheme for the pathologic assessment of LBs and Lewy neurites (LN) using alpha-synuclein immunohistochemistry and semiquantitative grading of lesion density, with the pattern of regional involvement being more important than total LB count.
Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials.
- Medicine, PsychologyJAMA
- 2005
Atypical antipsychotic drugs may be associated with a small increased risk for death compared with placebo, and this risk should be considered within the context of medical need for the drugs, efficacy evidence, medical comorbidity, and the efficacy and safety of alternatives.
Brain infarction and the clinical expression of Alzheimer disease. The Nun Study.
- Medicine, PsychologyJAMA
- 1997
Findings suggest that cerebrovascular disease may play an important role in determining the presence and severity of the clinical symptoms of AD.
Access to diagnostic evaluation and treatment for dementia in Europe
- Medicine, Political ScienceInternational journal of geriatric psychiatry
- 2007
A multidisciplinary approach based on close collaboration between GPs and specialised memory clinics may be the ideal model for early accurate diagnosis and subsequently early pharmacological and psychosocial interventions.
Clinical practice with anti-dementia drugs: a consensus statement from British Association for Psychopharmacology
- Psychology, MedicineJournal of psychopharmacology
- 2006
Although the consensus statement dealt largely with medication, the role of dementia care in secondary services (geriatric medicine and old age psychiatry) and primary care, along with health economics, was discussed.